ANNUAL REPORT 2017 1
E Department
of Oncology
UNIVERSITY OF CALGARY
Annual Report 2017
CUMMING SCHOOL OF MEDICINE
Department of Oncology
1 DEPARTMENT OF ONCOLOGY
Message from Head, Department of Oncology
Dr. Sunil Verma It is my privilege and honor to share the Department of Oncology Section Head for Gynecologic Oncology. Gregg is an established
2017 Annual Report. The report highlights the tremendous and recognized researcher with a focus on enhanced recovery
Professor and Head, Department achievements of our staff along with sharing our strategic and key after surgery, access to care for our indigenous population, and
of Oncology Cumming School of direction for the department moving forward. innovations in cancer surgery. We are sure that these leaders will
Medicine, University of Calgary continue to build on our strong legacy of Divisional leadership.
In 2016, the Department of Oncology framed and presented the key
Medical Director, Tom Baker Cancer strategic priorities that will help to direct our growth, recruitment and This past year we also focused on facilitating access to research
CentreCancer Control Alberta, Alberta focus on key research and academic aims. We set forth the vision support and funding for our researchers and staff. We established
Health Services and key strategic pillars as outlined here with a focus on ensuring the Oncology Research Office along with launching seed grant
optimal care while building a leading research program. competition to help junior and mid-career faculty have access
Vision to resources that will set the stage for future success.
Over this past year, we have been successful in establishing the
Creating a future without cancer. leadership and structure for these key initiatives that will help us We also would like to recognize the important partnerships and
accelerate the research aims. Dr. Winson Cheung, an established collaborations that are needed for the Departmental members to
Mission leader in the field of Health Services Research, was recruited and succeed. CancerControl Alberta, under the provincial leadership
has established the Alberta Cancer Outcomes Research Network of Dr. Matt Parliament and Nancy Guebert with local leadership
To improve cancer patient care (ACORN) to help facilitate Health Services Research across the of Ms. Teresa Davidson provides us with our home to provide care
and health outcomes through province. As part of the research strategic aims, we have also to our patients and support for the research and academic activities
integrated programs in cancer appointed Dr. Daniel Heng as the new Medical Lead for the Clinical that are pursued by our staff and researchers. The strategic
prevention, patient care, Research Unit. The CRU is a pivotal program to help ensure that we framework for research and future vision of our research aims
research, and education. provide access to our patients with innovative new therapies along has also been done with coordination and guidance of Dr. Greg
with collaborating with institutes and organizations around the Cairncross, the Director of the Charbonneau Cancer Institute, our key
world to support clinical research to help improve patient outcomes. partner is helping build a strong Cancer Research Program in Calgary.
The CRU has excelled under the leadership of Dr. Gwyn Bebb from
2012 till present and we look forward to Dr. Heng’s leadership has This past year, our staff and Department members were fully
he works to grow and strengthen this program. engaged in helping us design the new Calgary Cancer Centre,
set to open its doors in 2023. The journey ahead is very bright
Our success in the Department of Oncology is dependent on the for our Department as we aim to work together within our current
excellent work done by our individual members along with visionary research programs and help to continue to strengthen, grow, and
leadership of our Divisional leaders. We have outstanding Divisional foster partnerships to set the stage for the move to the new
leaders that have focused on providing support for their members Calgary Cancer Centre over the next five years.
along with recruiting and growing research programs to help strive
for a productive, leading, and high performance Department. We I would like to personally thank the members of our Department and
would like to acknowledge the leadership of Drs. Ivo Olivotto who our administrative and clinical staff that work tirelessly to provide
after 4 years as Division Head of Radiation Oncology decided to exceptional care and contribute to the academic mission of our
retire in April 2018. Dr. Corinne Doll was appointed the interim Department. We dedicate this report to your efforts and we will
Division Head and helped to maintain and grow the academic aims continue to provide our full support to you as you set new heights
for our Division and as of September 1st, 2018, Dr. Lisa Barbera, a for our Department.
renowned Radiation Oncologist with a focus on Health Services
Research and patient focused care took the role as Section Head Sincerely,
for Division of Radiation Oncology. Dr. Jill Nation, the Section Head
for Gynecologic Oncology, stepped down from this role after greater
than two decades of leadership. Dr. Gregg Nelson is the new
ANNUAL REPORT 2017 2
Table of Contents 1
3
Message from Department Head 4
Strategic Plan 5
Leadership 6
Academic Awards and Achievements 7
Academic Activity 8
Staff Profile and New Recruitments
Education Profile 9
Divisions of Oncology 11
13
Oncology Educational Program 15
Gynecologic Oncology 17
Hematological Oncology 19
Medical Oncology 21
Medical Physics 23
Palliative Medicine 25
Paediatric Oncology 27
Preventive Oncology 29
Psychosocial Oncology 31
Radiation Oncology 33
Surgical Oncology 35
Translational Laboratories
Department Of Oncology Members
Partners
3 DEPARTMENT OF ONCOLOGY
Strategic Plan
Strategy Framework Vision
We will achieve our vision and mission Creating a future without cancer
through our Research FOCI, Strategic
Pillars and Enabling Strategies
Mission
To improve cancer patient care and health outcomes through integrated
programs in cancer prevention, patient care, research, and education.
Research FOCI
Precision Psychosocial Prevention and Alberta Cancer Innovative Clinical
Oncology and and Survivorship Risk Reduction Outcomes Radiation Research Unit
Experimental Research and Surgical
Therapeutics Research Network Techniques (CRU)
(ACORN)
(POET)
Strategic Pillars
Advancing our Embracing Building Capacity, Fostering Team
Research FOCI our Research Mentoring and Work and
Leadership Culture Supporting
Researchers Collaboration
Enabling Strategies
Funding
Infrastructure
Communication and Profile
ANNUAL REPORT 2017 4
Leadership
Provincial and Calgary Leadership Roles - 2017
Department of Oncology Leadership: Dr. Wendy Smith New appointed Leadership positions
Dr. Sunil Verma Division Head, Medical Physics Dr. Doug Stewart
Department Head (Clinical and Academic) Senior Medical Director Cancer SCN
Medical Director, TBCC Medical Lead, Dr. Jessica Simon
Calgary Cancer Project Division Head and Section Chief, Dr. Winson Cheung
Palliative Medicine Medical Director, Provincial Health
Dr. Peter Duggan Services Research, CancerControl
Deputy Clinical Department Head, Dr. Victor Lewis Alberta; Co-Program Lead, ARCC,
Deputy Medical Director, TBCC Division Head and Section Chief, HSSP Research Program
Paediatric Oncology
Dr. Lloyd Mack Dr. Amanda Roze des Ordons
Deputy Academic Department Head Dr. Christine Friedenreich Residency Program Director,
Division Head, Preventive Oncology Palliative Medicine
Dr. Tien Phan
Associate Medical Lead, Calgary Dr. Barry Bultz Dr. Russell Loftus
Cancer Project Division Head, Psychosocial Oncology Deputy Residency Program Director,
Palliative Medicine
Dr. Vincent Tam Dr. Ivo Olivotto
Associate Director of Education Division Head and Section Chief, Dr. Lyle Galloway
Radiation Oncology Palliative Care Physician Lead
Dr. Jill Nation
Division Head and Section Chief, Dr. Greg McKinnon
Gynecologic Oncology Division Head and Section Chief,
Surgical Oncology
Dr. J. Dean Ruether
Medical Director, Community Oncology
Dr. Peter Duggan
Division Head and Section Chief,
Hematological Oncology
Dr. Don Morris
Division Head and Section Chief, Medical
Oncology Acting Scientific Director,
Translational Laboratories
5 DEPARTMENT OF ONCOLOGY
Academic Awards and Achievements
Academic Promotions Department of Oncology Awards
Hematological Oncology: 2016
Dr. Ahsan Chaudhry • Luminary Award for Teaching: Dr. Claire Temple-Oberle
Clinical Assistant Professor
• Young Investigator Award for Excellence in Research:
Medical Physics: Dr. Harvey Quon
Dr. Charles Kirkby
Adjunct Associate Professor • Team Award for Innovation: Drs. Robyn Banerjee,
Michael Roumeliotis, Tyler Meyer, Kundan Thind,
Paediatric Oncology: Gregg Nelson
Dr. Greg Guilcher
Associate Professor • Excellence in Research Award: Dr. Daniel Heng
Palliative Medicine: • Gavin Stuart Award for Clinical Excellence
Dr. Srini Chary and Professionalism: Dr. Marc Webster
Clinical Assistant Professor
• Certificate for Clinical Excellence: Dr. Michel Henin
Dr. Marisa Dharmawardene
Clinical Assistant Professor 2017
• Young Investigator Award: Dr. Darren Brenner
Psychosocial Oncology:
Dr. Steve Simpson (Molecular Epidemiology)
Emeritus
• Luminary Award for Teaching: Dr. Prafull Ghatage
Radiation Oncology: (Gynecologic Oncology)
Dr. Robyn Banerjee
Clinical Associate Professor • Gavin Stuart Award for Clinical Excellence and
Professionalism: Dr. Michael Speca
Dr. Tien Phan (Psychosocial Oncology)
Clinical Associate Professor
• Team Award for Innovation: OASIS program team
Dr. Theresa Trotter Dr. Lauren Walker, Dr. John Robinson, Reanne Booker NP,
Honorary Clinical Associate Professor Dr. Corinne Doll, Dr. Tien Phan, Dr. Sarah Glaze, Kerrie
Brennan RN, Carly Sears, Natalie Jacox, Dr. Andrea Beck,
Dr. Roanne Millman, Dr. Jill Turner, Dr. Erica Wiebe, Amy
Driga OT, Ashley Auyme, RT
ANNUAL REPORT 2017 6
Academic Activity
Grants - 2017
Division Number of Grants 2017 Amount Total Amount Total 2017 grant amount
Gynecologic Oncology 35 $6,994,059 $6,994,059 $54,261,248
Hematological Oncology 16 $1,147,965 $1,147,965
Medical Oncology 37 $4,292,287 $9,471,538
Medical Physics 2
Palliative Medicine 14 $68,872 $428,566
Paediatric Oncology 35 $6,445,947 $19,234,361
Preventive Oncology 36
Psychosocial Oncology 56 $215,752 $1,370,364
Radiation Oncology 14 $8,034,038 $36,699,667
Surgical Oncology 10 $7,819,253 $32,850,543
Fundamental Research 38
TOTAL 293 $838,750 $3,150,000
$2,814,445 $16,201,585
$15,589,880 $15,589,880
$54,261,248 $143,138,528
Academic Publications - 2017
Gynecologic Oncology 20 Total 2017 publications
Hematological Oncology 102
Medical Oncology 141 578
Medical Physics
Palliative Medicine 31
Paediatric Oncology 28
Preventive Oncology 28
Psychosocial Oncology 54
Radiation Oncology 69
Surgical Oncology 35
Fundamental Research 26
TOTAL 44
578
7 DEPARTMENT OF ONCOLOGY
Staff Profile and New Recruitments
Sta New Recruitments
39 Academic GFT vs. Dr. Anna Dr. Paola Neri Dr. Winson
72 Clinical Members Cameron Hematology Cheung
Gynecologic Medical
113 Academic GFT Oncology Dr. Gloria Oncology
Clinical Roldan-Urgoiti
Clinical Adjunct Dr. Nancy Nixon Medical Dr. Kundan
Medical Oncology Thind
Department of Oncology Medical Physics
Oncology – 224 members Dr. George
Dr. Ravi Shah Francis Dr. Darren
Gender Distribution Paediatric Physiatry Brenner
Department of Oncology Oncology Preventive
Oncology
81 Female
143 Male Dr. Petra
Grendarova
Dr. Fiona Schulte Dr. Jeffrey Cao Radiation
Psychosocial Radiation Oncology
Oncology Oncology
ANNUAL REPORT 2017 8
Education Profile
Education 40 Education Statistics Since 2015
352
15/16 11
Legend 16/17 15 40 411
Fellows 17/18 20 32 431
Residents
Trainees
18/19 23 33 433
2018/19 Division Education Statistics
Gynecologic Oncology Malignant Hematology &BMT Medical Oncology Medical Physics Palliative Medicine
Fellows 18/19 Fellows 18/19 Fellows 18/19 Fellows 18/19 Fellows 18/19
Residents 2 Residents 2 Residents 8 Residents 1 Residents 0
Trainees 7 Trainees 4 Trainees 6 Trainees 3 Trainees 0
58 60 74 9
138
Paediatric Hematology Oncology Psychosocial Oncology Radiation Oncology General Surgery
Fellows 18/19 Fellows 18/19 Fellows 18/19 Fellows 18/19
Residents 3 Residents 4 Residents 2 Residents 1
Trainees 4 Trainees 1 Trainees 5 Trainees 3
0 19 48 27
9 DEPARTMENT OF ONCOLOGY
Oncology Educational Program
Dr. Vincent Tam, BSc(Hon), Highlights 2017 Program Directors
MD, FRCP(C)
Associate Director With respect to Undergraduate Medical Education (UME), the national objectives for Dr. Prafull Ghatage
of Education oncology teaching in the UME curriculum were created in 2015. A curriculum blueprint Gynecologic Oncology
mapping out oncology teaching in the Cumming School of Medicine UME curriculum
Division Statistics was then prepared and revisions to oncology teaching were initiated in the fall of 2016 Dr. Mona Shafey
and are currently ongoing. Hematological Oncology
Trainees
489 The new combined curriculum format was implemented in July and September 2017. Dr. Jan-Willem Henning
Residents All the program directors were surveyed and asked to rank the relative importance Medical Oncology
32 of prior combined curriculum topics. Suggestions for additional important general
Fellows oncology topics were also requested. The highest ranked topics were prioritized for Alana Hudson
23 presentations during the first weeks of July and September 2017. Evaluations of the Medical Physics
Rotating Residents/ presentations were positive and attendance was significantly improved compared
Students to the previous format. Dr. Amanda Roze des Ordons
431 Palliative Medicine
The residency programs continue to plan for transitioning to Competency-Based
Medical Education (CBME). Medical Oncology is the first oncology specialty program Dr. Greg Guilcher
set to adopt CBME in July 2018. Paediatric Oncology
Residents and Fellows Research Day was held on June 16, 2017. 17 residents Dr. John Robinson
and fellows representing 6 oncology divisions presented their research. The best Psychosocial Oncology
presentations were awarded to Dr. Lana Sacaragic (Gynecologic Oncology),
Dr. Omar Khan (Medical Oncology) and Dr. Jessica Conway (Radiation Oncology). Dr. Shaun Loewen
Radiation Oncology
We continue to observe a general growth in trainee numbers as shown in the tables
on page 8. A total of 19 fellows were in the Department of Oncology in 2017 and they Dr. Lloyd Mack
were funded through Alberta Cancer Foundation, Department of Oncology, the Lilian Surgical Oncology
Koch Gynecologic Oncology Fellowship, supervisor research grants and locum funding.
2017 Fellowship Directors
The new Grand Rounds format implemented in 2016 continues to be relatively
successful. They are held once a month and focus on a practice changing topic within Dr. Scot Dowden
each division. The MAiD presentation by Dr. Jackson Wu and Dr. James Pinilla, as well Medical Oncology
as the medical cannabis presentations by Dr. Marc Kerba and Dr. Rizwan Qureshi were
particularly well attended and well received. Dr. Andrew Daly
Bone Marrow Transplant (BMT)
Dr. Lesley Street
Lymphoma
Dr. Harvey Quon
Radiation Oncology
ANNUAL REPORT 2017 10
Department of Oncology Trainees MEDICAL PHYSICS PALLIATIVE MEDICINE
GYNECOLOGIC ONCOLOGY PSYCHOSOCIAL ONCOLOGY
HEMATOLOGICAL ONCOLOGY
PAEDIATRIC HEMATOLOGY/ONCOLOGY
MEDICAL ONCOLOGY
GENERAL SURGICAL ONCOLOGY
RADIATION ONCOLOGY
11 DEPARTMENT OF ONCOLOGY
Gynecologic Oncology
Section Chief and/or Overview Awards and Achievements
Division Head:
Dr. Jill G. Nation, MD, Gynecologic Oncology has a strong focus on leadership in educational programs. Dr. Jill Nation: Association of Professionals
FRCSC – Professor Our Royal College approved fellowship program, of which Dr. Prafull Ghatage is in Obstetrics and Gynecology (APOG),
the Director, attracts high quality applicants from Canada and abroad. In 2017, Carl Nimrod Award. This national award
Deputy Section Chief we had 7 fellows in our program with several completing Masters Degrees while recognizes excellence, commitments, innovation
and/or Division Head: training with us. Dr. Pamela Chu is the Assistant Dean, Postgraduate Medical and leadership demonstrated in teaching,
Dr. Gregg Nelson, MD, PhD, Education at the Cumming School of Medicine (0.3FTE) and has been involved in knowledge, attitudes and skills to the next
FRCSC, Associate Professor simulation initiatives in PGME as well as minimally invasive surgery simulation generation of practitioners; December, 2017
teaching as the Obstetrics and Gynecology Simulation Curriculum Lead until
Division Statistics June, 2017. Dr. Sarah Glaze is the Department of Obstetrics and Gynecology Dr. Pamela Chu: Golden Speculum Award;
Coordinator for Continuing Medical Education and is in charge of organizing Clara Christie Research Day, Department of
Sta weekly Grand Rounds in Obstetrics and Gynecology. In 2017 she became the O&G; May 12, 2017
6 Education Head for the Department of Obstetrics and Gynecology as well as a
Publications national committee member for the Competency by Design (CBD) initiative of the Dr. Gregg Nelson: Department of Oncology
20 Royal College of Physicians and Surgeons of Canada. Team Innovation Award 2017, Interstitial
Grants Gyne Brachytherapy Team, Tom Baker Cancer
35 Dr. Anna Cameron joined the Gynecologic Oncology Group in July 2017 as Centre: September, 2017. Appointed Vice Chair,
Value of Grants a post-doctoral fellow with 0.4 FTE clinical appointment after completing her Gynecologic Oncology Specialty Committee,
$6,994,059 Master’s in Epidemiology from Harvard TH Chan School of Public Health in Royal College of Physicians and Surgeons
Presentations/ May 2017. Her current post-doctoral research is focused on an economic of Canada. Invited to Editorial Board of
Symposiums evaluation of the pan-Canadian BRCA initiative. International Journal of Gynecologic Cancer
25
Dr. Anna Cameron: Completed Master in
Dr. Jill Nation is the Medical Director of Colposcopy in the Calgary Zone as well Epidemiology from Harvard TH Chan School
as a member of the Provincial Colposcopy Subcommittee of the Alberta Cervical of Public Health: May, 2017
Cancer Screening Program (ACCSP). Highlights involve development of an
electronic Alberta colposcopy report through SCM which will be available to all
provincial colposcopy groups and provide the provincial screening program with
accurate, timely data. Liaison with the Women’s Health Centre colposcopy clinic
and working with their management team was critical for this latter activity as
well as development of standardized referral and consult request documents.
ANNUAL REPORT 2017 12
“The Gynecologic Oncology Division at TBCC is extremely proud of the results achieved with
our Enhanced Recovery After Surgery (ERAS) project. Through collaboration with our colleagues
at CCI, we implemented ERAS in our surgical patients starting in November 2017. In 367 ERAS
patients, mean compliance with ERAS care elements increased from 56% to 77%. Median length of
stay (LOS) for all surgeries decreased from 4 days to 3 days post-ERAS. In medium/high complexity
surgery, median LOS was reduced by 2 days. Complications prior to discharge decreased from 53%
to 36% post-ERAS. There was no significant difference in readmissions, complications up to 30
days, or mortality between the cohorts. The overall net cost savings to the healthcare system
was $462,000. We look forward to sustaining these gains in our population.” - Dr. Gregg Nelson
Clinical Highlights Research Highlights
In 2017, Dr. Sarah Glaze was a key participant in Over the past year, research activities have increased in this initiative internationally as Dr. Nelson is the
the Oasis Clinic (oncology and sexuality, intimacy and our Division. At the 2017 Clara Christie Research Day Chair of the Gynecology Section at ERAS International
survivorship) a multidisciplinary clinic for sexual health of the Department of O & G, members of our division (Sweden). Numerous presentations and publications
following cancer treatment funded as a pilot project. presented or collaborated in 8 posters as well as one from this initiative are documented below. In addition,
In addition, the Go BRCA pilot – QI grant with medical oral presentation (which won best oral presentation). together with Dr. Barry Bultz from the division of
genetics was implemented in our division under Our division published 20 papers in 2017, presented Psychosocial Oncology, Dr. Nelson is involved with
Dr. Glaze’s leadership and is now being rolled out to 5 posters at national/international meetings, as well an international collaboration between Psychosocial
standard practice with national interest in this project. as giving 25 presentations. Division members were Oncology researchers and oncologists at the University
involved in research projects with fellows in our training of Calgary and researchers in Australia. This work has
Introduction of Colposcopy pre-invasive procedures program resulting in presentations at the Department acted as a catalyst to allow for Calgary to be chosen to
at the TBCC Holy Cross Colposcopy Clinic and working of Obstetrics and Gynecology and Department of host the 2nd World Indigenous Cancer Conference
with the colposcopy team to create an electronic Oncology Research Days. (Dr. Nelson is on the Executive of the planning
colposcopy treatment workbook has decreased committee). Finally, both Dr. Nelson and Dr. Sarah Glaze
pressure on wait times for these cases in the operating Dr. Gregg Nelson has provided research leadership are heavily involved in the EHVINA project
rooms and provided a systematic method to handle all for our group in the Enhanced Recovery after Surgery (Enhancing HPV Vaccination in First Nations
requests for these procedures. (ERAS) program, which was implemented in our division Populations in Alberta).
in 2016 and is now being used to drive changes in
care. The TBCC Gynecologic Oncology group is leading
13 DEPARTMENT OF ONCOLOGY
Hematological Oncology
Section Chief and/or Overview Awards and Achievements
Division Head:
Dr. Peter Duggan MD, In 2017 the Division of Hematology welcomed two new faculty members, Dr. Carolyn Owen: 2017 was co-author for
FRCPC. Clinical Associate Dr. Kareem Jamani and Dr. Sonia Cerqouzzi. Dr. Jamani completed hematology 2 New England Journal of Medicine publications
Professor of Medicine and bone marrow transplant fellowships in Calgary followed by an advanced
BMT fellowship year at the Fred Hutchinson Cancer Center. His clinical and Dr. Paola Neri: Awarded 2 oral presentations
Deputy Section Chief research interests include graft versus host disease and survivorship issues for her research “Single Cell Resolution Profiling
and/or Division Head: following transplant. Dr. Cerquozzi is also a graduate of the Calgary hematology Defines the Innate and Adaptive Immune
Dr. Andrew Daly, Director training program, and subsequently completed a fellowship year in Repertoires Modulated By Daratumumab and
Provincial Bone Marrow myeloproliferative disorders at the Mayo clinic. IMiDs Treatment in Multiple Myeloma (MM)”
Transplant Program and “Transcriptional Plasticity Compensates
Dr. Douglas Stewart was appointed Senior Medical Director of the for Ikaros and Aiolos Proteasomal Degradation
Dr. Carolyn Owen, Cancer Strategic Clinical Network for Alberta. and Mediates Resistance to IMiDs in Multiple
Hematology Tumour Myeloma (MM)” and was invited to chair a
Group Lead The bone marrow transplant program in Calgary, performed 100 autologous and session at the American Society of Hematology’s
82 allogeneic transplants and performed the first ever adult transplant for sickle annual general meeting
Dr. Man-Chu Poon, cell anemia in Canada, and for the first time used engineered immune cells for
Rare Blood and Bleeding treatment of infectious complications of HCT in Alberta. Calgary is recognized Dr. Kareem Jamani: Presented an oral session
Disorders Director for world-class results in transplantation of patients with autoimmune diseases. entitled “Quality of Life of Informal Caregivers
of Hematopoietic Cell Transplant Recipients”
Dr. Deepa Suryanarayan, The TBCC implemented extended weekday hours and weekend outpatient at the American Society of Hematology’s
Thrombosis Program Lead clinics. This allowed the hematology program to begin to provide 7-day per week annual general meeting
outpatient therapy to patients. Treatment regimens and supportive care previously
Division Statistics administered on an inpatient unit can now be given entirely as an outpatient. Dr. Andrew Daly: Served as president of the
As a result, a significant number of admissions have been avoided. Canadian Blood and Marrow Transplant Group
Sta
30 The BMT service began offering outpatient conditioning prior to bone Dr. Lynn Savoie: Served as president of the
Publications marrow transplantation. Canadian Hematology Society
102
Grants Dr. Ahsan Chaudhry: Promoted to Clinical
16 Assistant Professor
Value of Grants
$1,147,965 Dr. Mona Shafey: Cumming School of Medicine
Presentations Silver award for teaching, Course 1
43
Book Chapters
3
ANNUAL REPORT 2017 14
“The Hematology, Bone Marrow Transplant and
cellular therapy programs remain on the cutting
edge of new therapies for cancer.” Dr. Peter Duggan
Clinical Highlights Research Highlights
The Hematology, Bone Marrow Transplant and cellular The Division of Hematology values the opportunities
therapy programs remain on the cutting edge of new that clinical and translational research provides for
therapies for cancer. In 2017, the first successful patient care. Whenever possible, clinical trials are
transplant for an adult with Sickle Cell Disease was offered in major tumour types as well as less common
performed in Calgary, potentially curing this lifelong disorders, bone marrow transplant, and supportive
disorder. Tailored cellular therapies are now possible in care. In 2017 there were at least 29 active clinical trials
Calgary for patients with resistant infections following enrolling 226 patients and providing close to $3 million
bone marrow transplantation. dollars in research, along with almost $1 million in other
research grant funding. World renowned translational
The first 2 patients with Fabry disease treated research programs in multiple myeloma and bone
with gene therapy occurred in Calgary in 2017 marrow transplant immunology provide a basis for
(Autologous Stem Cell Transplantation of Cells the development and evaluation of new therapies,
Engineered to Express Alpha-Galactosidase A in and support the potential of personalized medicine
Patients With Fabry Disease). Both patients have in Calgary.
had an increase in leukocyte alpha-galactosidase
activity and the first patient was weaned off enzyme
replacement therapy approximately 1 year after
the treatment.”
15 DEPARTMENT OF ONCOLOGY
Medical Oncology
Section Chief and/or Overview Awards and Achievements
Division Head:
Dr. Don Morris, MD, PhD, Medical Oncology continues to be challenged with increasing new patient, follow Dr. Nimira Alimohamed: Medical Oncology
FRCPC up and treatment patient numbers. This has stressed both individual clinics Fellow’s Teaching Award for Best Clinical
and the systemic treatment areas. Although there has only been an 0.6 FTE Preceptor 2017
Deputy Section Chief newly funded medical oncology staff position over the last six years, we have
and/or Division Head: been able to utilize locums tenens, clinical associates and nurse practitioners in Dr. Cynthia Card: Pfizer Clinical Preceptor
Dr. Jan-Willem Henning, association with optimized clinic processes to accommodate. In addition, the use Teaching Award, Medical Oncology Training
MBChB, FRCPC of funds freed up from seconded positions to alternate AHS positions has allowed Program 2017
contracted MO FTE to be created. The creation of Saturday/Sunday treatments for
Division Statistics select patient populations has already occurred and increased hours of operation Dr. Desiree Hao: Commendation Letter for
will be looked at in 2018 to provide increased cost-effective capacity. Mentorship in Internal Medicine Residency
Sta Mentorship Program 2017
26 (TBCC/Regional) Targeted recruitment into the area of health service research has allowed
Publications investigation into best patient care and has elevated academic productivity Dr. Winson Cheung: 2017 Ralph Meyer Young
141 significantly. The creation of the department research office will facilitate Investigator Award, CCTG
Grants grant/ethics application administration and the implementation of a universal
35 consent for cancer patients should yield dividends over the next several years in Dr. Daniel Heng: Meritorious Service Cross,
Value of Grants the areas of precision medicine and health research services. A new academic Governor General of Canada on behalf of
$4,292,287 evaluation metric will be rolled out in 2018 that transparently quantifies academic Her Majesty Queen Elizabeth II
Presentations/ and clinical productivity allowing merit-based allocation of protected time for
Symposiums our medical oncologists. Academic support for our Medical Oncology Divisional Dr. Sasha Lupichuk: 2017 Medical Oncology
214 colleagues in Lethbridge, Medicine Hat and Red Deer in the form of support for Fellows’ Teaching Award for Evidence-Based
Book Chapters clinical trials and collaborations with the TBCC in the areas of best practice and Medicine, Division of Medical Oncology,
3 health services research are ongoing. Tom Baker Cancer Centre
“2017 has been an exceptional year for the Division of Medical Oncology Dr. Nancy Nixon: Early Career Research
Program New PI Award, Canadian Institutes
with successes in the areas of recruitment, education, research (Precision of Health Research-Institute of Cancer Research
(“CIHR-ICR”), Talent in Oncology Program
Award (Boehringer Ingelheim for Provincial
Lung Group), Young Investigator Forum Award
(3rd Annual Young Investigators Forum in
Non-Small Cell Lung Cancer, Prime Oncology)
Dr. Dean Ruether: Pathfinder’s Award, ProstAID
Calgary, which recognizes individuals who have
contributed significant service to helping men
and their families deal with prostate cancer
Medicine and Health Service Research) and exceptional clinical care.
Cannot wait to see what we can accomplish in 2018!” - Dr. Don Morris
ANNUAL REPORT 2017 16
Dr. Jeffrey Graham: ASCO Merit Award Winner
for Cytoreductive nephrectomy in metastatic
papillary renal cell carcinoma
Dr. Adriana Matutino: ASCO Merit Award
Winner for The Impact of age in the quality
of life of patients diagnosed with breast cancer
after curative treatment
Dr. Haider Samawi: ASCO GI Merit Award
Winner for A real-world comparison of
multi-modality therapies in locally advanced
gastro-esophageal tumours
Clinical Highlights 2017 and has been instrumental in several clinical Research Highlights
process initiatives. Dr. Dean Ruether received the
The successful recruitment of Drs. Nancy Nixon, Pathfinder’s Award from ProstAID Calgary for his Despite very busy clinical service demands the
Winson Cheung and Safiya Karim joining our yeoman’s work with the Prostate cancer group over Medical Oncology Division has published over
Medical Oncology membership in 2017 has been the last decade. Drs. Pabani, Samawi and Alghamdi 140 manuscripts with 5 medical oncologists
a real highlight. Dr. Nixon has joined our Breast and have all provided significant clinical expertise and publishing over 10 papers this year. Similarly, our
Lung Cancer tumour groups and has already been service in their roles as locum tenens. Our clinical number of peer reviewed grants and associated
successful in publishing over 6 publications this year, fellowship program has continued to expand under per year funding has continued to exceed previous
has received over 600k in peer reviewed funding the tutelage of Dr. Karim. years. Significant philanthropic and industry grants
and has been awarded an Early Career Research have also been awarded to Drs. Bebb, Monzon, Tang,
Program New PI Award from the Canadian Institutes Dr. Tsang has helped lead us through the Stewart, Nixon and Morris. Dr. Heng received the
of Health Research Institute of Cancer Research. ConnectCare EMR transition and Drs. Henning and very prestigious Governor General Meritorious Service
Dr. Winson Cheung was recruited to the position of Alimohamed are leading the charge through the Award for his international standing and contributions
Medical Director, Provincial Health Services Research new RCPSC Competency by Design evaluation in the Renal Cell Carcinoma. Similarly, Dr. Winson
as of January 1, 2017, in addition to his clinical role initiative for our Medical Oncology training program. Cheung was awarded the coveted 2017 Ralph Meyer
within the GI tumour group and truly represents our Dr. Doug Stewart has been appointed to the role Young Investigator Award from the Canadian Clinical
first successful recruitment into a Clinician Scientist of Senior Medical Lead for the Provincial Cancer Trials Group (NCIC). Awards have been garnered
position and has already made incredible strides in Strategic Clinical Network (SCN) and Dr. Desiree Hao by Drs. Nimira Alimohamed, Cindy Card and Sasha
forming the nidus of an internationally recognized was elected as the new Secretary/Treasurer of the Lupichuk for our annual Educational Teaching
Health Services Program. Dr. Safyia Karim comes to Canadian Association of Medical Oncologists. Awards. Our clinical fellows’ Drs. Adriana Matutino,
us from Heath Services Research Fellowship training Jeffrey Graham and Haider Samawi have all been
with Dr. Chris Booth at Queen’s University and has awarded prestigious ASCO Merit awards. Overall
already been very productive with 11 publications in an exceptional academic year for the group.
17 DEPARTMENT OF ONCOLOGY
Medical Physics
Section Chief and/or Overview Awards and Achievements
Division Head:
Dr. Wendy L. Smith, PhD, 2017 was a busy and productive year in Medical Physics. Our major clinical focus Dr. Leigh Conroy
FCCPM, MCCPM for the first half of the year was the renovation of vault 5 and installation of a Queen Elizabeth II $5,000
TrueBeam Edge linear accelerator with micro MLC. Our linac-based SRS program University of Calgary Ruby Doctoral Scholarship
Division Statistics was transitioned from the BrainLab system to this device. As an interim step $12,000 (2016-2017)
and for redundancy, an existing TrueBeam accelerator was also commissioned AAPM Science Council Associates Mentorship
Sta for SRS treatments. The first Truebeam SRS treatment was delivered in January Program Award $4,000 US (2016-2017)
12 2017. Unit 5 was delivered in March, and a major upgrade to the AriaRO system
Publications (to version 13.6) was performed in June. The first SRS treatment on the new unit Amy Frederick
31 was delivered in June 2017. The entire SRS program was transitioned from Unit Dean’s Doctoral Scholarship $15,000
Grants 3 to Unit 5 by August, when Unit 3 was removed from service. Room 3 is now Warren Veale Doctoral Entrance $1,000
2 being renovated and a second, matched Truebeam Edge will be installed starting Queen Elizabeth II $3,600
Value of Grants in April 2018. Additionally, a multi-disciplinary process improvement project Queen Elizabeth II (Masters)
$68,872 was undertaken to increase treatment capacity, resulting in current capacity of $7,200 (2016-2017)
Presentations/ 5 SRS patients per week. The second half of the year, our major priority was to Faculty of Graduate Studies Travel Award
Symposiums commission high dose rate brachytherapy for prostate. This treatment can be used $500 (2016-2017)
26 to treat prostate cancer which extends beyond the prostate capsule, extending
treatment options in these patients, and has been shown to improve biochemical Dr. Brandon Koger
relapse free survival when used to boost external beam radiotherapy. The first Eyes High International Doctoral Scholarship
HDR prostate patient was treated in January 2018. Other major clinical projects $12,000 (2016-2017)
include rolling interstitial brachytherapy for gynecological cancers into Faculty of Graduate Studies Travel Award
the brachytherapy treatment program and implementation of spine SBRT. $500 (2016-2017)
2017 also saw some major personnel changes. Dr. Sarah Quirk completed her Svetlana Kuznetsova
fellowship and joined the staff in the Division in August. Two long time members Queen Elizabeth II $10,800
of our division, Dr. Eduardo Villarreal-Barajas and Ferenc Jacso moved on to
positions in England and Alaska, respectively. Recruitment for their replacements Steven Nich
is on-going. In the meantime, three locum are covering clinical duties. Graduate Queen Elizabeth II $3,600
students, Leigh Conroy and Brandon Koger, successfully defended their PhDs,
while Amy Frederick completed her MSc. Resident Casey Bojechko completed his Rebecca Frederick
residency and a brief fellowship and joined the staff at the University of California NSERC $17,500
San Diego (UCSD).
Dr.Elizabeth Watt
CIHR $35,000/yr x 3 yrs
Departmental Graduate Student
Excellence Award $250
Queen Elizabeth II $5,000 (Jan-Apr 2017)
ANNUAL REPORT 2017 18
Awards and Achievements
Matthew Skarsgard
Alberta Innovates Summer Research Studentship
Award $6,000
Sarah Weppler
NSERC/CGS-D $70,000
Faculty of Graduate Studies Doctoral Scholarship
$10,000 (2016-2017)
Queen Elizabeth II (Doctoral)
$15,000 (2016-2017)
Drs. Michael Roumeliotis, Tyler Meyer,
Kundan Thind
Team Innovation Award, Department
of Oncology, University of Calgary
“Clinical experience inspiring
Clinical Highlights Research Highlights research questions. Innovative
The treatment delivery and verification research group Our academic program hosted 11 graduate students, solutions informing excellence
conducted research into planning and delivery in three summer students, three undergraduate project
challenging circumstances, including moving targets students, three fellows and three residents this in clinical care.” - Dr. Wendy Smith
and for changing patient characteristics. Our breast year. Research foci have been developed in breast
focus resulted in multiple papers on deep-inspiration radiotherapy, brachytherapy and volumetric arc
breath hold treatments, as well as treatment planning radiotherapy. A number of research grants were
techniques for partial breast radiotherapy. This group obtained, and our students brought in $233,950.00 in
also hosted clinicians from two other institutions scholarships and awards. The research done by these
interested in implementing our breast radiotherapy groups was recognized not only by publications and
technique. The Brachytherapy group published abstracts, but by changing practice. For instance, two
several papers on patient outcomes and dosimetry radiotherapy groups have come to observe our breast
for brachytherapy seeds. deep-inspiration breath hold delivery technique,
with an aim to implementing it at their own clinics.
19 DEPARTMENT OF ONCOLOGY
Palliative Medicine
Section Chief and/or Overview Awards and Achievements
Division Head:
Dr. Jessica Simon MB ChB, The Palliative Medicine division continues to promote the full integration of a Dr. Jessica Simon
MRCP (UK) palliative care approach into cancer care, as well as to develop integration within Covenant Health: Best Poster Award Palliative
the care of people living with advanced, life-limiting, non-cancer illnesses. We and Education Research Day, Provincial,
Division Statistics support education, research and a comprehensive clinical service across sectors Research
of the healthcare system that seek to enhance the quality of life and experience
Sta of people living with serious illness. Dr. Shane Sinclair
30 CIHR- Institute of Cancer Research
Publications In research, our collaborative project Palliative Care Early and Systematic New Investigator Award
28 (www.PaCESProject.ca) led by Dr. Jessica Simon and Dr. Ayn Sinnarajah with
Grants Dr. Patricia Tang and Dr. Marc Kerba from the Gastrointestinal Oncology tumour Faculty of Nursing Graduate Teaching
14 group and others in Cancer Care Alberta and Family Medicine, was successful in Excellence Award (Nominee)
Value of Grants securing both Canadian Institutes of Health Cancer Control Partnerships in
$6,445,947 Health System Improvement and Alberta Health grant funding. Dr. Eric Wasylenko
Presentations/ Foothills Canada 150 Medal.
Symposiums In education, one collaborative highlight was a series of joint rounds between
81 Surgery, Oncology & Palliative Medicine organized by Dr. Srini Chary and YPO Canada: Best Personal Development Event
presented by Dr. Alexandra Easson from the Department of Surgery at the 2017 – ‘Inevitable Change- preparing your loved
University of Toronto. Another, was that Dr. Amanda Roze Des Ordons ones Or your inevitable end of life’
(cross-appointed from Department of Critical Care) became the Residency
Program Director for the Division of Palliative Medicine and completed the Nomination finalist: AHS President’s Excellence
application for the new Royal College of Physicians and Surgeons of Canada Awards 2017 (Category - Outstanding
sub-specialty in Palliative Medicine, while the prior conjoint Residency program Achievement in Patient and Family-Centered
director, Dr. Jacqueline Hui, was appointed as the Family Medicine Enhanced Care and Quality Improvement)
Skills Palliative Care Residency Program Director.
ANNUAL REPORT 2017 20
Clinical Highlights Research Highlights “We are working together to
achieve Choosing Wisely Canada’s
Our collaborative approach was a feature of success Health Services Research remains our primary Oncology recommendation:
at a National level in 2017. Clinically, the Calgary Zone, focus. The PaCES project seeks to provide earlier Don’t delay or avoid palliative
Alberta Health Services Palliative/End of Life Care and ongoing access to coordinated, comprehensive care for a patient with metastatic
Program, in which our division members serve, was and compassionate palliative care to improve quality cancer because they are pursuing
a Canadian Foundation of Healthcare Improvement of life for Albertans with advanced cancer (initially, disease-directed treatment.”
(CFHI) 2017 Palliative and End-of-Life Care Innovation with colorectal cancer) and evaluate the patient and
Award Recipient for demonstrating comprehensive, health system outcomes of this approach. Our other - Dr. Jessica Simon
integrated and tailored palliative care in all urban and flagship research program on advance care planning
rural health sectors. In addition the Alberta Health research program (www.ACPCRIO.org) was in its
Services Provincial Emergency Medical Services fourth year and hosted a pre-conference symposium
Palliative and End-of-Life Care Assess, Treat and Refer and was a major contributor to workshops and
Program (EMS PEOLC ATR) that was spread from an posters at the International Society of Advance
innovation by Dr. Lindy Murphy in Calgary, was also a Care Planning and End of Life care (ACPEL), held
CFHI 2017 Palliative and End-of-Life Care Innovation in Banff, AB. Other division research continues in
Award Recipient. themes of medical education, compassion and
community engagement.
21 DEPARTMENT OF ONCOLOGY
Paediatric Oncology
Section Chief and/or Overview Awards and Achievements
Division Head:
Dr. Victor A. Lewis, MD The blood and marrow transplant program at the Alberta Children’s Hospital Sickle Transplant Alliance for Research (STAR)
continues to grow and advance new techniques and technologies. 100% survival Inaugural Annual Meeting Banff AB - June 2017
Division Statistics with absence of any graft versus host disease in transplanted individuals is an
outstanding achievement seen in our initial cohort of patients. This success has Paediatric Oncology Experimental Therapeutic
Sta generated national and international interest for study collaboration with local Investigator Consortium (POETIC) annual
8 team members leading the effort in children. The primary immune deficiency meeting (Canmore, Alberta) - July 2017
Publications transplant program has also used a novel transplantation regimen to improve
28 outcomes of transplantation in the ‘highest’ risk patients. Greater than 90%
Grants of children transplanted are surviving with minimal transplant related mortality
35 and morbidity. Ultimately the innovation from these two programs is aimed
Value of Grants at improving outcomes while reducing costs to the system.
$215,752
Presentations The ‘Hospital at Home program’ for children in paediatric oncology has grown over
12 the years and has made visible changes to the census on the inpatient unit. More
Symposiums chemotherapies and supportive care therapies are being provided in the comfort
2 of homes with an aim to minimize disruption to family and home environment. The
Book Chapters program has been well received by families and caregivers alike. At the provincial
2 and national level there has been considerable interest in developing similar
programs for adults and children elsewhere.
The program graduated three fellows this year. Two fellows have pursued further
training with one in Blood and Marrow Transplantation at Alberta Children’s
Hospital with a focus in haplo-identical transplantation as well as developing the
unrelated donor transplantation program for Sickle cell disease, while the second
is pursuing further training in hemoglobinopathies at Hospital for Sick Children in
Toronto. Two new fellows joined the program. We continue international out-reach
with local experts providing education in Kenya, while developing collaborations
and helping develop programs in Kenya. Our sixth international fellow started his
position this year in Paediatric Hematology/Oncology/BMT.
ANNUAL REPORT 2017 22
Research Highlights Local endeavors continue with efforts to publish our “Like all academic programs, Paediatric
Sickle Cell transplant experience as well as outcomes
The entire team endeavors to promote local and of primary immune deficiency transplant experience. Oncology strives for excellence in
collaborative research. Precision medicine remains Our section won the Paediatric innovation awards
the focus of new approaches for difficult to treat for new innovative research advancing Sickle Cell research and innovation. Our Hospital
cancers. Two initiative are soon to materialize with transplant sciences as well as another award for
open studies available to our patients. Precision advancing clinical and psychosocial sciences with at Home Program exemplifies such an
Oncology for Young People (PROFYLE) is a our ‘Hospital at Home Program’. Calgary holds the
pan-Canadian effort funded by the Terry-Fox largest collaborative infant brain tumour registry and innovation. Delivering chemotherapy
foundation, while Paediatric Oncology Experimental publications from that annotated database continue.
Therapeutic Investigator Therapeutic Consortium The Sickle Cell Transplant Alliance consortium (STAR) and other supportive care in the comfort
(POETIC), a US collaboration (of which we are the and POETIC groups held their annual meetings
only Canadian member) will also be opening a study in Banff and Calgary respectively. Such meetings of children’s home has helped reduce
in Calgary. Local leadership is heading a Canada increase our stance and visibility in respective
wide endeavor to study an important question research consortia. stress within families, allowed them to
in transplant for acute lymphoblastic leukemia in
children and adolescents. The study is expected keep living their lives closer to normal
to open in Canada in 2018.
and made the situation more bearable
Children’s oncology group enrollments continue on
open studies while we continue to open studies in in such stressful times.” - Dr. Victor Lewis
collaboration with Industry and various Canadian
and US partnerships.
23 DEPARTMENT OF ONCOLOGY
Preventive Oncology
Section Chief and/or Overview Awards and Achievements
Division Head:
Dr. Christine Friedenreich, The Division of Preventive Oncology had 10 members that includes the Research Dr. Darren Brenner held a Career Development
PhD, FCAHS Scientists in the Department of Cancer Epidemiology and Prevention Research Award in Prevention from the Canadian Cancer
(CEPR) who are Drs. Darren Brenner, Christine Friedenreich, Karen Kopciuk Society, $75,000 annually for 3 years
Division Statistics and former members of the Department Drs. Nigel Brockton (American Institute (July 2015-June 2018). Dr. Darren Brenner
of Cancer Research, Arlington VA) and Ilona Csizmadi (Cedars-Mt Sinai, received the $500,000 Armstrong
Sta Los Angeles). Other members include: Dr. Heather Bryant, (Canadian Partnership Investigatorship in Molecular Epidemiology
10 Against Cancer, Toronto), Dr. Lorraine Shack (Director, Cancer Surveillance of at the Cumming School of Medicine,
Publications CancerControl Alberta, AHS), Dr. Jeff Vallance (Associate Professor, Athabasca University of Calgary (2017-2022)
54 University, Medicine Hat), Ms. Xanthoula Kostaras (Manager, Guidelines
Grants Utilization Resource Unit, CancerControl Alberta) and Ms. Melissa Shea-Budgell Dr. Christine Friedenreich held an Alberta
36 (Lead, Research Strategy and Partnerships, Arnie Charbonneau Cancer Institute, Innovates-Health Solutions Senior Health
Value of Grants Cumming School of Medicine). Our Division also had two postdoctoral fellows, Scholar Award (ended in 2017) and the Alberta
$8,034,038 Dr. Jessica McNeil (supervisors: Drs. Friedenreich and Brenner) who holds CIHR Cancer Foundation Weekend to End Women’s
Presentations and AI postdoctoral fellowships and Dr. Chel Hee Lee who was funded by a CIHR Cancers Breast Cancer Endowed Chair
78 grant (supervisor: Dr. Karen Kopciuk). (2012-2017)
Book Chapters
1 Dr. Cheryl Peters was recruited as a new Research Scientist in the Department of Dr. Christine Friedenreich was elected as
CEPR and joined the Division in March, 2018. Dr. Darren Brenner was recruited the Canadian representative for the Scientific
for the tenure track Molecular Epidemiologist at the Assistant Professor level Council, International Agency for Research
through the Cumming School of Medicine in October 2017. The position is one on Cancer, World Health Organization, Lyon,
of the priority areas within the Precision Medicine initiative and was a joint France (2018-2021)
recruitment between the Departments of Oncology and Community Health
Sciences. Recruitment for two additional Research Scientists in the Department of Dr. Jeff Vallance received an Award for
CEPR was initiated in fall 2017. Excellence in Graduate Student Supervision
(AEGSS) and his graduate student also won
The Department of CEPR held a retreat in December 2017 to update its three the Governor General’s Gold Medal in 2017.
year strategic plan. The main areas of focus will be to continue increasing Dr. Vallance holds a Tier II Canada Research
capacity through recruitment of new Scientists and trainees, to increase the Chair in Health Promotion and Chronic Disease
research productivity and impact of the research in cancer prevention and to Management ($500,000 / 5 years, renewable)
work collaboratively with other groups in Alberta towards the creation of an
Alberta Center for Cancer Prevention Research.
ANNUAL REPORT 2017 24
Research Highlights “We were immensely pleased with the
recruitment in October 2017 of Dr. Darren
The division scientists’ research continues to be funding during this past year from the Canadian Brenner into the Armstrong Investigatorship
focused on a range of topics in cancer epidemiology Institutes of Health Research (CIHR), the Cumming in Molecular Epidemiology in the Cumming
and prevention with a major emphasis on lifestyle School of Medicine, the Alberta Cancer Foundation School of Medicine in one of their new tenure
factors, molecular and genetic mechanisms of cancer and the Canadian Patient Safety Institute. track Precision Medicine positions. Dr. Brenner
etiology and survival. In addition, research is on-going is rapidly being recognized internationally as
in areas of health services, cancer surveillance, and One large on-going project being co-led by Drs. a rising star in molecular and genetic cancer
cancer survivorship. Brenner and Friedenreich, funded by the Canadian epidemiology. He brings his inquisitive mind,
Cancer Society Research Institute, is the ComPARe rigorous scientific approaches, passion for
For the reporting period of January 1, 2017 to project that is quantifying the current and future training the next generation of scientists to
December 31, 2017, our Division members have held burden of cancer attributable to lifestyle, environment, address questions in primary, secondary and
$27,571,561 in grant funding, $1,225,000 in career and infections in Canada. Other large cohort studies tertiary prevention of cancer with a particular
awards and $823,383 in infrastructure grants. In in breast cancer survivorship are on-going focus on colorectal, lung and breast cancers.”
addition, they have published 54 papers and made (Alberta Moving Beyond Breast Cancer Cohort
76 presentations at scientific meetings. The Division study and the Breast to Bone Metastases study). Dr. Christine Friedenreich
scientists have been successful in securing new
25 DEPARTMENT OF ONCOLOGY
Psychosocial Oncology
Section Chief and/or Overview Awards and Achievements
Division Head:
Dr. Barry D. Bultz, PhD, In 2017, with generous support from the Daniel Family Foundation, we added one Dr. Linda Carlson
Professor FTE academic staff member, Dr. Fiona Schulte. Dr. Schulte came from the Alberta Dr. Rogers Prize in Complementary and
Children’s Hospital and will be spearheading our academic Pediatric, AYA and Alternative Medicine Shortlist, 2017
Daniel Family Leadership Childhood Survivorship Psychosocial Oncology program.
Chair in Psychosocial Dr. Fiona Schulte
Oncology Importantly, in 2017, The Division of Psychosocial Oncology, Department Avenue Magazine Top 40 Under
of Oncology at the Cumming School of Medicine signed a Memorandum of 40 Award. 2017
Division Statistics Understanding with School of Medicine and Public Health, Faculty of Health
and Medicine, University of Newcastle, Callaghan, NSW, Australia. President Elect, Canadian Association
Sta of Psychosocial Oncology, 2017-2018
18 The Division also added 3 new adjuncts, Dr. Brian Kelly, the Dean of Medicine
Publications for Newcastle University, Dr. Carole Mayer, Director of Research and Regional Dr. Barry Bultz
69 Clinical Lead, Supportive Care Oncology Program, Health Sciences North and Fellow, American Psychosocial Oncology
Grants Fred Ashbury, Professor, Illawarra Medical Health Research Institute, University Society, the first non-American to receive
56 of Wollongong, NSW Australia. this honour, 2017
Value of Grants
$7,819,253 With support of the Daniel Family Leadership Chair, in 2017, the Division was Daniel Family Leadership Chair in Psychosocial
Presentations/ able to host several visiting scholars: Professor Neil Aaronson (Amsterdam), Oncology, Department of Oncology, Cumming
Symposiums Head of the Department of Psychosocial Research, Division of Psychosocial School of Medicine, University of Calgary,
101 Research and Epidemiology at the Netherlands Cancer Institute and Professor 2016-2021
in the Department of Clinical Psychology at the University of Amsterdam, where
he holds a Chair in Quality of Life in Chronic and Life-Threatening Illness. Conjoint Professor, School of Medicine and
Dr. Brian Kelly, (Australia), the Dean of Medicine for Newcastle University, Public Health, Faculty of Medicine and Health,
& Dr. Amy Waller, (Australia), Research Fellow, School of Medicine and Public University of Newcastle, Australia
Health, University of Newcastle. As well, the Division hosted a one day Indigenous
and Rural Cancer Care Communities: Round Table Meeting to help understand Dr. John Robinson
and collaborate in Indigenous program and service delivery. Finally, The Research Supervision Award, Department
International Psycho-Oncology Society has agreed to cohost a World Congress of Psychology, University of Calgary, 17
in Psycho-Oncology with the Canadian Association of Psychosocial Oncology
in Banff, Alberta in 2019. Dr. Lauren Walker
Canadian Psychological Association President’s
New Researcher Award – $500, 2017
ANNUAL REPORT 2017 26
“Advancing the Science of Caring- through
Research Highlights Research, Education, Innovation and
Collectively, with our 56 grants, for the year of 2017, Clinical Training” - Dr. Barry Bultz
we brought in about $ 7,819,253.21 & collectively over
$32,750,542.01 CDN dollars’ worth of grants.
27 DEPARTMENT OF ONCOLOGY
Radiation Oncology
Section Chief and/or Overview Awards and Achievements
Division Head:
Dr. Ivo Olivotto, Radiation In 2017, the division saw one new recruit, one departure and the loss of one of our Dr. Shaun Loewen: Quality of Life Award
Oncologist, MD, FRCPC colleagues, Dr. Jon-Paul Voroney. The division now included 24 members (23 FTE) from University of Calgary Radiation Oncology
including Dr. Liu in Red Deer and Drs. Wilson and Ghose in Lethbridge. Residents (for the faculty member most
Deputy Section Chief contributing to the Residents’ overall experience
and/or Division Head: Dr. Jeff Cao, a graduate of the University of Alberta (MD 2005) and joined the in the training program), 2017
Dr. Elizabeth Kurien faculty in March 2017, after Fellowships with the BCCA and CPQR. He is the Dr. Harold Lau: Preceptor of the Year Award
new radiation oncology lead of the breast cancer tumour group. as voted by members of the University of
Division Statistics Calgary Radiation Oncology Residents, 2017
Innovations and practice changes in the past year have included:
Sta Strategic Planning
24 a) The implementation of the MAiD consultation service
Publications A divisional retreat was held on June 2, 2017
35 b) Evolution of brachytherapy services and expertise in gynecologic to assess key priorities and define/redefine
Grants and prostate cancers. group actions for the next three years. After
14 collaborative discussion, it was agreed that
Value of Grants c) The inter-disciplinary clinic to support women with sexual health sequelae three action priorities for division members
$838,750 related to cancer or its treatment. The OASIS clinic is staffed by Department include:
Presentations of Oncology faculty from the Divisions of Radiation Oncology (Drs. Corinne
30 Doll and Tien Phan), Gynecologic Oncology (Dr. Sarah Glaze) and Psychosocial • Centre of Excellence in Brachytherapy
Book Chapters Oncology (Drs. Lauren Walker, John Robinson) and nursing expertise
1 (Reanne Booker, NP, Kerrie Brennan, RN). • Body SBRT Innovation across tumour groups
and disease sites
d) Switching from a more complicated stereotactic radio-surgery technique
for patients with brain metastases and certain benign tumours, to a linear • Prospective electronic collection of Patient
accelerator-based, ARC therapy technique, reducing the RT planning and Reported Outcomes at the point of care
delivery time and increasing treatment capacity within existing resources.
e) Stererotactic Body Radiotherapy for localized prostate cancer which converts
a 38 treatment visit regimen delivered over 7-8 weeks of daily visits to the
cancer centre into a 5-treament regimen delivered over 2 weeks.
ANNUAL REPORT 2017 28
Research Highlights “We have advanced the delivery of personalized radiotherapy
• Radiation therapy is a fundamental treatment used as part of a comprehensive person-centered approach to care.
in the treatment of patients with cancer, and is used
for cure, palliation, or treatment consolidation with We will embody the values of professionalism, respect, diversity
other modalities.
and compassion in our daily work.” - Dr. Lisa Barbera
• Our division members have been actively involved
in improving clinical care for Albertans with cancer,
through technologic advances and research. The
research activities by our division members span
the basic science/translational to local, national
and international clinical trials and health services,
quality of life, and patient-reported outcomes.
• Our Fellowship program had two clinical research
fellows Dr. Kitty Huang from the Western University
of London Regional Cancer Program, London, Ontario
and Dr. Soumyajit Roy from University who completed
his residency in Radiation Oncology from All India
Institute of Medical Sciences and thereafter pursued
a year of fellowship in BC Cancer under University
of British Columbia.
29 DEPARTMENT OF ONCOLOGY
Surgical Oncology
Section Chief and/or Overview Awards and Achievements
Division Head:
Dr. J. Gregory McKinnon, Dr. Mack became President of the Canadian Society of Surgical Oncology and the Dr. Lloyd Mack
MD FRCSC, Professor of Chair of the Post-Graduate Surgical Training Committee. He continues as Acting 2017 PGME Appreciation Award for
Surgery and Oncology Deputy Head of the Department of Oncology, and Director of Cancer Surgery Outstanding Commitment to Residency
Alberta where there are now more than 60,000 synoptic reports captured. Education for the General Surgical Oncology
Division Statistics Dr. Temple-Oberle received the PARA resident physician well-being award and Subspecialty Program
also assumed the leadership of the Department of Surgery Research Office. She Associate Dean’s Letter of Recognition for
Sta continues to lead the provincial initiative in breast reconstruction and became the teaching contributions to the Clerkship in the
7 world lead of the ERAS program in breast reconstruction. Breast Reconstruction 2016-2017 Academic year, Cumming School
Publications Awareness Day (BRA) continues to grow and Dr. Temple-Oberle hosted another of Medicine, University of Calgary
26 successful BRA day in October 2017 in Calgary. Dr. Temple-Oberle organized
Grants the Caring on Empty: Compassion Fatigue Workshop for Oncology Staff, Dr. Claire Temple-Oberle
10 Surgeons’ Day, BRA Day (both public and CME), and Residents’ Research Day. 2017 PARA resident physician well-being award
Value of Grants Dr. Walley Temple organized and hosted a national conference on patient reported
$2,814,445 outcomes (PROs). Dr. Quan was a founding member of the Alberta Cancer
Presentations Outcomes Research Network (ACORN) and became an Associate Professor
21 in the Department of Community Health Studies. Dr. McKinnon continues as
Symposiums Section Chief/ Division Head for the Surgical Oncology.
2
Dr. Bathe secured funding for the Pan-Canadian Enhanced Pancreatic Cancer
Profiling for Individualized Care (EPICC) Program. He continues as leader of the
Provincial GI tumour team, and co-chair, Hepatobiliary Group, GI Tumor Group, and
Canadian Cancer Trials Group. Members of the division participated in multiple
international health projects including Ecuador, Haiti, and Laos. Four members
completed research sabbaticals in 2017 and members held approximately
17 million in grant funding. Surgical Oncology Fellow Dr. Eva Thiboutot
graduated and accepted a teaching position at the University of Montreal.
Our administrative team was awarded for excellence this year at the Department
of Oncology Annual Recognition Dinner. Deborah Powers, administrative assistant
for Dr. Walley Temple, was the recipient of the Natural Leader Award. Natalie
Jacox, administrative assistant for Dr. Lloyd Mack, was the recipient of the
Innovations/ Great Ideas Award.
ANNUAL REPORT 2017 30
Research Highlights • Contemporary use of staging laparoscopy in the “Excelling in leadership and accomplishment
management of gastric cancer; Dr. Dan Schiller;
• Retrospective validation of the University of Dr. Lloyd Mack & Dr. Michael McCall in service, academics, administration and
Calgary protocol for neoadjuvant chemoradiation
before potentially curative surgery; Dr. Michael • Critical incidents and effective debriefing: A Calgary international health.” - Dr. Walley Temple
Monument, Dr. Elizabeth Kurien, Dr. Lloyd Mack resident survey; Dr. Lloyd Mack & Dr. William Kent
& Dr. Shannon Puloski
• 2017 Royal College Robert Maudsley Fellowship
• Retrospective analysis of macroscopic and for Studies in Medical Education; Dr. Claire
microscopic features of appendectomy specimens Temple-Oberle
of low-grade mucinous neoplasm (LAMN) with
regards to their possible prognostic significance; • Awarded IIT Grant - A Protocol for Mobile
Dr. Xianyong Gui & Dr. Lloyd Mack App Postoperative Home Monitoring after
Enhanced Recovery Oncologic Surgery;
• Quality of life after cytoreductive surgery and Dr. Claire Temple-Oberle
heated intraperitoneal chemotherapy: A Canadian
perspective; Allison Fyfe; Dr. Antoine Bouchard- • Inspiring hope – A physician’s responsibility,
Fortier; Dr. Lloyd Mack; Dr. May Lynn Quan translating the science into clinical practice;
& Dr. Walley Temple Dr. Walley Temple
31 DEPARTMENT OF ONCOLOGY
Translational Laboratories
Scientific Director: Overview
Dr. Don Morris, MD, PhD,
FRCPC The TBCC Translational Laboratories (TransLab) acts as an infrastructural bridge
linking basic research to clinically useful deliverables for precision medicine.
Operational Lead: Activities are focused on impacts to support and improve health outcomes for
Ms. Rose Farrell, MSc cancer patients, reduce costs and improve efficacy of screening, diagnosis, and
treatment. TransLab actively collaborates with health professionals, industry
Unit Leads: partners, academic centers and research collectives to maximize the value of
Molecular – Dr. JB McIntrye, studies – the growing list of clientele includes 48 local Principal Investigators
PhD and 25 external/industry clients.
Functional Tissue Imaging – Strategic Planning/Priorities
Ms. Angela Chan, MSc
Pharmacokinetics – Mr. Bill
Kangarloo, MSc
Division Statistics The introduction of lean measures and improvements in Project Management has
helped TransLab to continue operations and deliver on on-going and pipeline projects
Sta while searching for alternative funding sources such as Genome Canada and Industry
8 collaborations. TransLab has been successful in attracting strategic partners both
nationally (Ontario Institute for Cancer Research) and Internationally (Moffitt
Publications Cancer Center).
23
TransLab is a unique entity that fills a gap between research and the clinic.
Grants Its presence has allowed for the timely adoption of field-leading novel assays
11 (i.e. MGMT/EGFR). The lab historically provided services for all of Alberta, as well as
other provinces (SK/MB/BC) for molecular oncology. Costs and turnaround times for
Value of Grants Albertans were reduced versus outsource testing to other centers (i.e. Mayo Clinic).
$500,000+ Currently, clinical public service laboratories (such as CLS/GLS) lack the resources
and in some cases the expertise to develop novel assays, incorporate companion
Presentations tests compromising Albertan’s benefit from new scientific discoveries. TransLab
18 is currently trying to act as a bridge across these shortcomings.
Symposiums
8
TransLab is an important component of patient care, and an area that is lacking in many
centers and provinces. Translational research is important for improving patient care
and treatment. Assay development is costly, but a critical, necessary quality
step in order to achieve future economic benefits and health impacts for Albertans.
ANNUAL REPORT 2017 32
A Translational Research entity is critical in helping clinical labs to keep up with rapidly
evolving technology and advances in discovery. Many novel tests are outsourced to
companies that charge large overhead (i.e. OncotypeDx >$4000/patient), instead of
developing and implementing in-house solutions (i.e. ProSigna/PAM50) that would
provide lower per patient costs and shorter turnaround times. In 2016, a customer
feedback survey was delivered with generally positive responses. There were some
concerns highlighted around cost restrictiveness and turnaround times. TransLab
has looked to improve in these areas wherever possible. Some notable suggestions for
improvement included: bringing molecular tests into the clinic, more interaction with
clinical tumour groups to stimulate collaborations, and availability of new platforms
such as the Life technology S5 sequencer (enabling cell free DNA and platform
molecular analysis) and the Vectra multi-fluorescent protein infrastructure (enabling
up to 7 colour protein staining that will allow immunological tumour microenvironment
analysis to be undertaken). Many of these Priorities/Strategies will harmonize well with
the Department of Oncology Precision Oncology Experimental Therapeutics (POET)
initiative. In addition, a logic model was created to demonstrate the path to Impacts
for TransLab, including Inputs (Stakeholders), Activities, Outputs, and Outcomes.
“Our vision is to facilitate translation
Research Highlights of research to the clinic by providing
The fee for services units of TransLab delivered Additionally, knowledge was disseminated discovery, testing and validation services:
billable work for 39 Projects during this period, in the form of abstracts, posters and oral
supporting 21 different clients (Including presentations. TransLab has established two distinct The right treatment for the right patient
researchers belonging to the Arnie Charbonneau revenue-generating service units (Molecular Analysis
Cancer Institute, the Department of Oncology, and & Functional Tissue Imaging) with specialized at the right time.
Calgary Lab Services, as well as Researchers from activities and reliable client portfolios. A third Unit
international institutions, organizations and the (Pharmacokinetics) receives core clinical funding Our mission is to provide high quality
pharmaceutical industry. via AHS and provides clinically accredited testing for
patient samples while conducting research activities. Proteomics, Genomics, Tissue Imaging, and
TransLab members had authorships on 23 different Additionally, the Bebb and Morris Research labs are
peer reviewed journal article publications over strategically integrated within the organization to Pharmacokinetic services for stakeholders
the 2017 reporting period. In addition, there were provide additional links from basic to clinical research,
numerous other publications that were enabled by stimulate collaboration, and synergize resources with to support translational research and
TransLab that did not receive authorship given the the service units.
cost recovery/service nature of the collaboration. clinical diagnostics contributing to the
provision of precision medicine for
our patients.” - Dr. Don Morris
33 DEPARTMENT OF ONCOLOGY
Department Of Oncology Members
Amane Abdul-Razzak Ted C. Braun Tina Cheng Joseph C. Dort Aaron A. Goodarzi Deirdre A. Jenkins
Clinical Assistant Professor Clinical Professor Associate Professor Professor Assistant Professor Clinical Associate Professor
Nimira S. Alimohamed Darren M.R. Brenner Winson Y.T. Cheung Scot D. Dowden Geoffrey T. Gotto L. Martin Jerry
Clinical Assistant Professor Assistant Professor Associate Professor Clinical Assistant Professor Clinical Associate Professor Honorary Clinical Professor
Ronald A. Anderson Malcolm L. Brigden Pamela Chu Peter R. Duggan Andrew J. Graham Victor H. Jimenez-Zepeda
Associate Professor Clinical Associate Professor Associate Professor Clinical Associate Professor Clinical Associate Professor Clinical Assistant Professor
Steve J. Angyalfi Nigel T. Brockton Jennifer A. Cobb Jacob C. Easaw Savraj S. Grewal Hatim Karachiwala
Clinical Associate Professor Adjunct Associate Professor Associate Professor Adjunct Associate Professor Associate Professor Clinical Assistant Professor
John P. Arlette Christopher B. Brown Simon J. Colgan Rosmin Esmail Sean C. Grondin Brian Kelly
Clinical Professor Professor Clinical Lecturer Adjunct Lecturer Professor Adjunct Professor
Fredrick D. Ashbury Heather E. Bryant Peter S. Craighead Markus Eszlinger Gregory M.T. Guilcher John J.P. Kelly
Adjunct Associate Professor Clinical Professor Clinical Professor Research Associate Professor Associate Professor Assistant Professor
Nizar J. Bahlis W. Donald Buie S. Nicole Culos-Reed David W. Falk David A. Hanley Marc Kerba
Associate Professor Professor Adjunct Professor Clinical Lecturer Clinical Professor Clinical Associate Professor
Chad G. Ball Barry D. Bultz Andrew S. Daly Clair F. Forestell Desirée Hao Charles J. Kirkby
Clinical Associate Professor Professor Clinical Associate Professor Clinical Assistant Professor Associate Professor Adjunct Associate Professor
Alexander G. Balogh Kelly W. Burak Indraneel Datta Eleanor Foster Adrian Harvey Karen A. Kopciuk
Clinical Associate Professor Professor Clinical Associate Professor Clinical Lecturer Clinical Associate Professor Adjunct Assistant Professor
Robyn N. Banerjee J. Gregory Cairncross Jeffrey C. Dawes George Francis Daniel Y. C. Heng Xanthoula Kostaras
Clinical Associate Professor Professor Clinical Lecturer Clinical Assistant Professor Clinical Associate Professor Adjunct Lecturer
Oliver F. Bathe Tavis S. Campbell Janet M. de Groot Christine M. Friedenreich Jan-Willem Henning Vanessa S. Krause
Professor Adjunct Assistant Professor Associate Professor Adjunct Professor Clinical Assistant Professor Clinical Assistant Professor
Tara L. Beattie Jeffrey Q. Cao Paula A. de Robles Lyle D. Galloway Leonie M. Herx Elizabeth C. Kurien
Associate Professor Clinical Assistant Professor Clinical Assistant Professor Clinical Lecturer Clinical Assistant Professor Clinical Assistant Professor
D. Gwyn Bebb Cynthia M. Card William G. deHaas Michelle N. Geddes Gilian C. Ho Habib A. Kurwa
Associate Professor Clinical Assistant Professor Clinical Assistant Professor Clinical Associate Professor Clinical Lecturer Clinical Professor
Tarek A. Bismar Linda E. Carlson Douglas J. Demetrick Gary A.J. Gelfand Alana Hudson Laura E. Labelle
Professor Professor Professor Clinical Assistant Professor Adjunct Lecturer Adjunct Assistant Professor
Walter B. Blahey Carole R. Chambers Marisa L. Dharmawardene Esmaeel Ghasroddashti Jacqueline Y-T Hui Martin J. LaBrie
Clinical Associate Professor Adjunct Assistant Professor Clinical Assistant Professor Adjunct Assistant Professor Clinical Assistant Professor Clinical Assistant Professor
Pinaki Bose Jennifer A. Chan Lisa M. DiFrancesco Prafull Ghatage J. Brad Hunter Lucie Lafay-Cousin
Adjunct Assistant Professor Associate Professor Associate Professor Associate Professor Clinical Lecturer Associate Professor
Antoine Bouchard-Fortier Shamir Chandarana Elijah Dixon Abhijit Ghose Siraj Husain René Lafrenière
Clinical Lecturer Clinical Assistant Professor Professor Clinical Assistant Professor Clinical Assistant Professor Professor
M. Avis Boyar Srinivasa (Srini) Chary Corinne M. Doll Janine Giese-Davis Seema Hussain Johannes C. Lategan
Clinical Lecturer Clinical Assistant Professor Clinical Associate Professor Associate Professor Clinical Assistant Professor Clinical Assistant Professor
Vivien H.C. Bramwell- M. Ahsan R. Chaudhry Bryan J. Donnelly Sarah J. Glaze Amal R. Imbulgoda Harold Y. Lau
Wesley Clinical Professor Clinical Assistant Professor Clinical Assistant Professor Assistant Professor Clinical Assistant Professor Clinical Associate Professor
ANNUAL REPORT 2017 34
Adrienne Lee S. Elizabeth McGregor Sara K. Pawlik M. Lynn Savoie Ronald N. Spice Theresa Trotter
Clinical Assistant Professor Adjunct Associate Professor Clinical Lecturer Clinical Associate Professor Assistant Professor Honorary Clinical Associate
Professor
Susan P. Lees-Miller J. Gregory McKinnon Guy Pelletier Colleen G. Schinkel J. MacGregor Steele
Professor Professor Adjunct Assistant Professor Adjunct Assistant Professor Clinical Associate Professor Tony H. Truong
Assistant Professor
Richard M. Lee-Ying John A. McWhae Tien Phan David C. Schriemer Joanne E. Stephen
Clinical Assistant Professor Clinical Associate Professor Clinical Associate Professor Professor Adjunct Associate Professor Chee-Ping Tsai
Adjunct Assistant Professor
Laurie Lemieux Daphne J.Y. Mew Tara L. Pickering Fiona S. M. Schulte Douglas A. Stewart
Clinical Lecturer Clinical Assistant Professor Clinical Assistant Professor Assistant Professor Professor Roger Y. Tsang
Clinical Assistant Professor
Victor A. Lewis Tyler S. Meyer Greg D. Pierce Donna L. Senger Jan Storek
Associate Professor Adjunct Assistant Professor Adjunct Assistant Professor Research Associate Professor Professor Franciscus A. Van der Hoorn
Professor
Gerald Lim Michael J. Monument Nicolas P. Ploquin Lorraine G. Shack Douglas R. Strother
Clinical Assistant Professor Assistant Professor Adjunct Assistant Professor Adjunct Assistant Professor Associate Professor Sunil Verma
Professor
Robert L. Lindsay Jose G. Monzon Man-Chiu Poon Mona Shafey Francis R. Sutherland
Clinical Associate Professor Clinical Assistant Professor Clinical Professor Clinical Assistant Professor Professor Lauren M. Walker
Adjunct Assistant Professor
Hong W. Liu Donald G. Morris May Lynn Quan Melissa A. Shea-Budgell Rachel M. Syme
Adjunct Assistant Professor Associate Professor Associate Professor Adjunct Lecturer Adjunct Assistant Professor Barbara A. Walley
Adjunct Associate Professor
Shaun Loewen Lindy Murphy Harvey C. Quon Jessica E. Simon Paul A. Taenzer
Clinical Assistant Professor Clinical Lecturer Clinical Assistant Professor Associate Professor Adjunct Assistant Professor Edwin Wang
Professor
Russell G. Loftus Aru Narendran Soundouss Raissouni J. Steven A. Simpson Vincent C. Tam
Clinical Lecturer Professor Clinical Assistant Professor Clinical Associate Professor Clinical Assistant Professor Eric Wasylenko
Clinical Associate Professor
Sasha M. Lupichuk Jill G. Nation Derrick E. Rancourt Shane Sinclair Patricia Tang
Clinical Assistant Professor Professor Professor Adjunct Assistant Professor Clinical Associate Professor Marc A. Webster
Clinical Assistant Professor
Paul R. MacEachern Gregory S. Nelson Karl T. Riabowol S. Richie Sinha Jason Tay
Clinical Associate Professor Associate Professor Professor Clinical Assistant Professor Associate Professor Jane M. Wilson
Clinical Assistant Professor
Lloyd A. Mack Ernesta P. Neri Stephen M. Robbins Aynharan Sinnarajah Walley J. Temple
Professor Associate Professor Professor Assistant Professor Professor Michael D. Wong
Clinical Assistant Professor
Enzio Magi Clinical Nancy A. Nixon John W. Robinson David P. Skarsgard Claire F. Temple-Oberle
Associate Professor Clinical Assistant Professor Adjunct Associate Professor Clinical Associate Professor Professor Nicola A.M. Wright
Clinical Associate Professor
Hubert K-M. Marr Ivo A. Olivotto Gloria B. Roldan Urgoiti Jiri Slaby Clinical J.F. (Ted) Thaell
Clinical Assistant Professor Clinical Professor Clinical Assistant Professor Assistant Professor Clinical Assistant Professor Jackson S.Y. Wu
Clinical Associate Professor
Jennifer Matthews Carolyn J. Owen Michael B. Roumeliotis Michael P. Slawnych Kundan S. Thind
Clinical Lecturer Associate Professor Adjunct Assistant Professor Clinical Assistant Professor Adjunct Assistant Professor V. Wee Yong
Professor
T. Wayne Matthews Ralf Paschke Amanda L. Roze des Ordons Wendy L. Smith Bejoy C. Thomas
Associate Professor Professor Clinical Assistant Professor Associate Professor Adjunct Assistant Professor
Carole Mayer Janice L. Pasieka J. Dean Ruether Michael Speca Alain Tremblay
Adjunct Associate Professor Clinical Professor Assistant Professor Adjunct Associate Professor Professor
Sean McFadden A. (Sandy) H.G. Paterson James A. Russell David P. Spencer
Clinical Assistant Professor Honorary Clinical Professor Honorary Adjunct Professor Adjunct Assistant Professor
35 DEPARTMENT OF ONCOLOGY
Partners
ANNUAL REPORT 2017 36
37 DEPARTMENT OF ONCOLOGY
Statement of Early construction Exterior shell NCCC will be substantial
requirements (SOR) activity included construction will be completed by PCL
document confirming excavation, shoring, complete. Operational and handed over to
scope of services and and initial foundation plans and budgets will AHS; operational
service requirements, work. Significant amount commissioning and
was established and of design work was be established. readiness activities,
incorporated into a completed at the 50%
Request for Proposal and 75% levels of design. 2020 including training and
(RFP) submission which move in plans, will be
was released in October. 2018
well underway
2016
2022
2015 2017 2019 2021 2023
Calgary Cancer FP responses were Full design to be Construction activity Calgary Cancer Center
Project (CCP) was evaluated and a contract completed in Spring; will focus on the fit will be operational to
officially announced was awarded to PCL and exterior structure is out of interior spaces. deliver care, and officially
by Government as the their partners DIALOG/ expected to reach the open to patients and
first Design Build (DB) 6th floor above grade. HR activities will
procurement project for STANTEC. First phase High level operational commence, including the the public.
an acute care health of schematic design planning strategy will recruitment of early hires.
facility in Alberta. with extensive user
engagement; official be developed. Operational readiness
ground breaking took plans will be established.
place in early Fall, 2017
Department of Oncology
Annual Report 2017
The words you are searching are inside this book. To get more targeted content, please make full-text search by clicking here.
Department of Oncology 2017 Annual Report
Discover the best professional documents and content resources in AnyFlip Document Base.
Search
Department of Oncology 2017 Annual Report
- 1 - 38
Pages: